WaferGen Biosystems
Life science company offering genomic tools for targeted resequencing, genotyping and expression analysis.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD68m (Public information from May 2016)
Fremont California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | IPO | |
| N/A | $6.3m | Post IPO Equity | |
| N/A | $5.1m | Post IPO Equity | |
$30.0m | Post IPO Equity | ||
| N/A | $30.6m | Growth Equity VC | |
| N/A | $15.0m | Growth Equity VC | |
| N/A | $50.0m Valuation: $50.0m | Acquisition | |
| Total Funding | CAD62.2m | ||
Related Content
Recent News about WaferGen Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.